HIM
KYNB

Hillhouse Investment Management’s Kyntra Bio KYNB Stock Holding History

Hillhouse Investment Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-107,448
Closed -$163M – 27
2018
Q3 		$163M Hold
107,448
– – 4.36% 6
2018
Q2 		$168M Buy
107,448
+3,354
+3% +$4.37M 2.87% 6
2018
Q1 		$120M Buy
104,094
+8,646
+9% +$11.4M 2.12% 13
2017
Q4 		$113M Sell
95,448
-4,000
-4% -$5.02M 1.92% 11
2017
Q3 		$134M Buy
99,448
+29,448
+42% +$31M 2.21% 9
2017
Q2 		$56.5M Buy
70,000
+30,000
+75% +$20.9M 0.87% 18
2017
Q1 		$24.6M Hold
40,000
– – 0.48% 20
2016
Q4 		$21.4M Buy
40,000
+19,494
+95% +$9.73M 0.48% 15
2016
Q3 		$10.6M Buy
20,506
+10,847
+112% +$5.11M 0.22% 22
2016
Q2 		$3.96M Buy
+9,659
New +$4.42M 0.1% 21

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hillhouse Investment Management's KYNB Position: Q4 2018 in Review

Hillhouse Investment Management sold out of Kyntra Bio (KYNB) in Q4 2018, closing a stake of 107,448 shares — an estimated $163M sold.

Hillhouse Investment Management first reported a position in KYNB in Q2 2016 and held it in 10 quarters. The position peaked at $168M in Q2 2018. 201 funds tracked by Wall St. Rank hold KYNB as of Q4 2018.

  • Hillhouse Investment Management reported no remaining Kyntra Bio position as of Q4 2018 after selling out during the quarter.
  • Hillhouse Investment Management sold 107,448 Kyntra Bio shares in Q4 2018, an estimated $163M.
  • Hillhouse Investment Management first reported a position in Kyntra Bio in Q2 2016 and held it in 10 quarters.
  • Hillhouse Investment Management's Kyntra Bio position peaked at $168M in Q2 2018.
  • 201 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2018.

Based on Hillhouse Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.